Eliminating Hepatitis C in Europe: A Report on Policy Implementation for People Who Inject Drugs. Civil Society Monitoring of Harm Reduction in Europe 2024
The latest report in the 2024 Civil Society Monitoring of Harm Reduction in Europe series explores developments in hepatitis C care for people who inject drugs, based on observations from C-EHRN focal points in 40 cities across 35 European countries. The findings point to trends such as expanded access to direct-acting antivirals (DAAs), ongoing healthcare stigma, and disparities in harm reduction funding. To gain further insights into this year’s report, we spoke with primary author Tuukka Tammi. Download the publication.
The publication is part of Correlation – European Harm Reduction Network’s Civil Society-led Monitoring of Harm Reduction in Europe 2024 Data Report, launched in 5 volumes: Hepatitis C Care, Essential Harm Reduction Services, New Drug Trends: Insights from Focus Group Discussions, European Drug Checking Trends 2018 – 2024 via TEDI and City Reports (Bratislava, Krakow, Rome, Prague).
